Description

Estandron famously distributed in its long-acting injectable format as Estandron Prolongatum is a vintage, multi-ester combination pharmaceutical formulation originally developed by Organon. It is highly distinct because it combines multiple esters of both the primary female sex hormone (Estradiol) and the primary male sex hormone (Testosterone) in a single sterile oil-based solution.

First introduced to the medical market in the 1956, Estandron was designed as a balanced, time-released cross-hormone therapy. While oral tablet versions containing ethinylestradiol and methyltestosterone were produced under the same brand name, the injectable depot format (Prolongatum) gained prominence for its highly prolonged release window of approximately 14 days per intramuscular administration.

Regulatory Notice: Because Estandron contains pure testosterone compounds, it is classified globally as a Schedule III Controlled Substance. Possession, distribution, or alternative usage without a lawful medical prescription is illegal. Furthermore, all variations are comprehensively banned in competitive sports by the World Anti-Doping Agency (WADA).

Product Specifications

Brand Names: Estandron, Estandron Prolongatum
Original Developer: Organon
Administration Method: Deep intramuscular injection (oil base)
Active Duration / Half-Life: Approximately 10 to 14 days due to heavy esterification
Market Status: Discontinued or phased out in major modern Western markets, though legacy generic formulations or chemical intermediates exist in certain global regions.

Active Ingredients Composition (Per 1 mL)

The multifaceted nature of Estandron Prolongatum relies on a highly calculated blend of short-, medium-, and long-chain esters:

Estradiol Benzoate (1 mg): A fast-acting estrogen ester providing sharp, initial systemic baseline coverage.
Estradiol Phenylpropionate (4 mg): A mid-acting estrogen ester providing progressive, sustained relief.
Testosterone Propionate (20 mg): A rapid-release androgen ester that quickly elevates systemic testosterone levels.
Testosterone Phenylpropionate (40 mg): A medium-acting androgen ester ensuring stable hormonal delivery.
Testosterone Isocaproate (40 mg): A long-chain androgen ester responsible for maintaining active hormone levels up to the 14-day threshold.

Historic Medical Applications & Indications : Estandron

Unlike traditional hormone replacement therapies (HRT) that focus on a single sex hormone, Estandron combined androgens and estrogens to treat complex conditions in women while mitigating select hormone-specific side effects:

Severe Menopausal Symptoms: Used to alleviate intense vasomotor conditions (hot flashes), night sweats, and vaginal atrophy. The inclusion of testosterones helped combat fatigue and muscle wasting while improving low libido.
Postmenopausal Osteoporosis: The combination of estradiol and testosterone worked in tandem to suppress bone resorption and stimulate collagen bone mineralization, protecting skeletal framework integrity.
Postpartum Lactation Management: Historically used to suppress unwanted milk production (lactation inhibition) following childbirth in specific clinical scenarios.

Off-Label & Underground Athletic Use (Illicit) : Estandron

Because it contains 100 mg of total testosterone esters per milliliter, Estandron Prolongatum is occasionally sought after by legacy users in underground athletic circles. However, it is fundamentally unsuitable for male bodybuilders due to the highly potent, integrated estradiol esters, which cause instant, severe estrogenic side effects in men. Conversely, it poses an immense danger of severe masculine changes in women.

Severe Side Effects and Health Risks

The compound carries a complex dual-hormone side effect profile:

Virilization in Women: Despite the balanced estrogen profile, the 100 mg matrix of testosterone can cause severe, irreversible masculine features in female patients, including deepening of the vocal cords, facial hair development (hirsutism), and clitoral enlargement.
Profound Endocrine Disruption: Totally overrides and shuts down natural hypothalamic-pituitary-gonadal axis loops, triggering natural hormone suppression.
Cardiovascular Strain: Alters basic lipid profiles, significantly lowering high-density lipoproteins (HDL “good” cholesterol) and raising low-density lipoproteins (LDL “bad” cholesterol), heightening the risk of blood clots, strokes, and arterial stress.
Estrogenic Complications: Can induce severe fluid retention (edema), migraine headaches, and extreme tenderness in breast tissues, and it is strictly contraindicated in anyone with a history of estrogen-dependent cancers or undiagnosed genital bleeding.